Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07120100 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors
A NA study of Gynecologic Cancer and Breast Cancer Female, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT07120100 is a NA study of Gynecologic Cancer and Breast Cancer Female that is actively recruiting participants, run by University of Utah. The registered enrollment target is 19 participants, below the 764-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07120100, a NA study of Gynecologic Cancer and Breast Cancer Female, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the change in pain scores among patients with chemotherapy-induced peripheral neuropathy after receiving treatment with repetitive transcranial magnetic stimulation (rTMS).
Conditions Studied
Interventions
- DEVICE rTMS
Study Locations (1)
Utah
- Huntsman Cancer Institute at University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2025-08-27 |
| Est. Completion | 2028-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07120100
The ClinicalTrials.gov registry entry for NCT07120100 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 764-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (98% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gynecologic Cancer appearing as the primary indexed condition, and to 1 intervention - of which rTMS is the first listed.
NCT07120100 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT07120100 about?
NCT07120100 is a clinical study titled "Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors". The goal of this study is to evaluate the change in pain scores among patients with chemotherapy-induced peripheral neuropathy after receiving treatment with repetitive transcranial magnetic stimulation (rTMS).
What is the current status of trial NCT07120100?
This trial is currently recruiting. It is a NA study. The enrollment target is 19 participants. The study started on 2025-08-27. Estimated completion is 2028-09-15.
What conditions does trial NCT07120100 study?
This clinical trial studies the following conditions: Gynecologic Cancer, Breast Cancer Female.
What interventions are being tested in trial NCT07120100?
The interventions under investigation include: rTMS (DEVICE).
Who is sponsoring clinical trial NCT07120100?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07120100 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
RECRUITING · NA
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Activity Coaching During Pelvic Radiation Therapy
RECRUITING · NA
-
Improve Cancer-related Cognitive Impairment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.